Category Archive

The Research Safety & Animal Welfare Administration (RSAWA) is pleased to announce the Spring 2020 3Rs funding opportunity, provided by the Office of the Vice Chancellor for Research. Aim of Award: The aim of the program is to promote and support pilot studies designed to replace the use of animals in research, reduce the numbers of animals necessary, or refine … Read More

The ARC recently revised the Policy, Tracking and Reporting Animal Numbers, to update reporting requirements for investigators that directly manage their own breeding and to clarify the process for reporting wild-caught animals and those studied in the field. The revised Policy is available at the Tracking and Reporting Animal Numbers web page. We encourage you to review the revised Policy … Read More

The Office of Research Administration (ORA) will observe UCLA’s 2019-20 Winter Holiday Closure. ORA will be closed beginning Saturday, December 21, 2019 and will reopen on Thursday, January 2, 2020. Please be advised that the Chancellor’s Animal Research Committee (ARC), Institutional Biosafety Committee (IBC), and Medical Radiation Safety Committee (MRSC) / Radioactive Drug Research Committee (RDRC) will not conduct business during … Read More

Please see the below announcement from Assistant Vice Chancellor for EH&S Colin Dimock regarding the new UCLA Biosafety Officer, Christine Tafoya. September 5, 2019 It is with great pleasure that we at the Office of Environment, Health & Safety announce the introduction of our new Biosafety Officer, Ms. Christine Tafoya. Christine comes to us from Bellingham, WA and is a … Read More

Within the Research Safety & Animal Welfare Administration (RSAWA), the ARC administrative team provides support to the Chancellor’s Animal Research Committee (ARC) by assisting researchers with: animal protocol submission and review, including application pre-review, submission processing, communicating and explaining ARC queries, and issuing approvals; required animal user trainings; facility inspections; interpretation and application of policies and regulations; and post-approval compliance … Read More

The ARC recently approved re-categorizing systemic or major organ (e.g., heart, liver, lung) perfusion from a non-survival surgery to a method of euthanasia for instances when tissues are only harvested after confirmation of death. Why the change: The ARC understands the burden that is placed on PIs when conducting animal research and periodically considers ways to remove unnecessary regulatory burden … Read More

The Research Safety & Animal Welfare Administration (RSAWA) is pleased to announce the Fall 2019 3Rs funding opportunity, provided by the Office of the Vice Chancellor for Research. Aim of Award: The aim of the program is to promote and support pilot studies designed to replace the use of animals in research, reduce the numbers of animals necessary, or refine … Read More

What are lab animal allergies and occupational asthma? Laboratory Animal Allergies (LAA) and Occupational Asthma (OA) develop from exposure to animal allergens, and are among the most common, serious occupational diseases of workers exposed to animals in laboratories. Please review the Lab Animal Allergies & Occupational Asthma fact sheet to learn how to prevent LAA and OA. The ARC encourages … Read More

The ARC has recently updated the Handling and Expiration Guidelines for Diluted Drugs and Fluids for Use in Research Animals. We encourage you to review these guidelines with your research team to ensure full understanding and compliance. In particular, please note that all drugs requiring dilution must be diluted and maintained using sterile technique, must be labeled, and expire 30 … Read More

Please see the below announcement from our friends in DLAM. Please contact Dr. Torres (CTorresUrbano@mednet.ucla.edu) or Ms. Schimmel (ASchimmel@mednet.ucla.edu) if you have any questions. MediGel Cups No Longer Available from Clear H2O – Carprofen Cups Are Available Ready-Made in the DLAM Pharmacy Until further notice, ClearH2O has made the decision, in consultation with the FDA, to stop the manufacturing, marketing … Read More